Compile Data Set for Download or QSAR
maximum 50k data
Found 35 Enz. Inhib. hit(s) with all data for entry = 50010067
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM12594(4-({4-[(6-CHLORO-1-BENZOTHIEN-2-YL)SULFONYL]-2-OXO...)
Affinity DataKi:  1.30nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090593(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  12nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090592(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  21nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090605(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  59nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090600(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  97nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090595(CHEMBL47654 | N-[2-(2-Amino-pyridin-4-yl)-ethyl]-2...)
Affinity DataKi:  140nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090597(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  140nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090604(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  160nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090596(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  170nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090613(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  250nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090615(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  270nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090594(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  340nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090609(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  430nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090611(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi:  620nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090603(CHEMBL295515 | N-[2-(2-Amino-thiazol-4-yl)-ethyl]-...)
Affinity DataKi:  620nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090607(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090610(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090608(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090599((S)-2-{2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090612(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090601(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090606(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090602((R)-2-{2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090614(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetCoagulation factor X(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090598(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.20E+3nMAssay Description:Compound was evaluated for the inhibitory activity against Coagulation factor XMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine protease 1(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090592(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >2.90E+3nMAssay Description:Compound was evaluated for the inhibitory activity against trypsinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetSerine protease 1(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090593(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >2.90E+3nMAssay Description:Compound was evaluated for the inhibitory activity against trypsin.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProthrombin(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090592(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >4.00E+3nMAssay Description:Compound was evaluated for the inhibitory activity against thrombinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetProthrombin(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090593(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >4.00E+3nMAssay Description:Compound was evaluated for the inhibitory activity against thrombinMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090592(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >7.30E+3nMAssay Description:Compound was evaluated for the inhibitory activity against plasminMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetPlasminogen(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090593(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >7.30E+3nMAssay Description:Compound was evaluated for the inhibitory activity against plasminMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue-type plasminogen activator(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090592(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >8.70E+3nMAssay Description:Compound was evaluated for the inhibitory activity against t-PAMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetTissue-type plasminogen activator(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090593(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >8.70E+3nMAssay Description:Compound was evaluated for the inhibitory activity against t-PA.More data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVitamin K-dependent protein C(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090593(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.80E+4nMAssay Description:Compound was evaluated for the inhibitory activity against Activated protein CMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed
TargetVitamin K-dependent protein C(Homo sapiens (Human))
Aventis Pharmaceuticals

Curated by ChEMBL
LigandPNGBDBM50090592(2-[4-(6-Chloro-benzo[b]thiophene-2-sulfonyl)-2-oxo...)
Affinity DataKi: >1.80E+4nMAssay Description:Compound was evaluated for the inhibitory activity against Activated protein CMore data for this Ligand-Target Pair
In DepthDetails ArticlePubMed